Interactions of Herbs with Cytochrome P450

REFERENCES

• Acquaviva R., Russo A., Campisi A., Sorrenti V., Di Giacomo C., Barcellona M. L., Avitabile M., Vanella A. Antioxidant activity and protective effect on DNA cleavage of resveratrol. J. Food Sci. 2002; 67: 137–141
   Web of Science ®Google Scholar
• Adedoyin A., Frye R. F., Mauro K., Branch R. A. Chloroquine modulation of specific metabolizing enzymes activities—investigation with selective five drug cocktail. Br. J. Clin. Pharmacol. 1998; 46: 215–219
   PubMed Web of Science ®Google Scholar
• Aggarwal A., Ades P. A. Interactions of herbal remedies with prescription cardiovascular medications. Coron. Artery Dis. 2001; 12: 581–584
   PubMed Web of Science ®Google Scholar
• Ahn D., Putt D., Kresty L., Stoner G. D., Fromm D., Hollenberg P. F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase ii enzymes. Carcinogenesis 1996; 17: 821–828
   PubMed Web of Science ®Google Scholar
• Akao T., Terasawa T., Hiai S., Kobashi K. Inhibitory effects of glycyrrhetic acid derivatives on 11 beta- and 3 alpha-hydroxysteroid dehydrogenases of rat liver. Chem. Pharm. Bull. 1992; 40: 3021–3024
   PubMed Web of Science ®Google Scholar
• Allen S. W., Mueller L., Williams S. N., Quattrochi L. C., Raucy J. The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human CYP1A1 expression. Drug Metab. Dispos. 2001; 29: 1074–1079
   PubMed Web of Science ®Google Scholar
• Almeida J. C., Grimsley E. W. Coma from the health food store: interaction between Kava and Alprazolam. Ann. Int. Med. 1996; 125: 940–941
   PubMed Web of Science ®Google Scholar
• Amagase H., Petesch B. L., Matsuura H., Kasuga S., Itakura Y. Intake of garlic and its bioactive components. J. Nutr. 2001; 955S–962S
   Google Scholar
• Ameer B., Weintraub R. A. Drug interactions with grapefruit juice. Clin. Pharmacokinet. 1997; 33: 103–121
   PubMed Web of Science ®Google Scholar
• Arivazhagan S., Nagini S., Santhiya S. T., Ramesh A. Protection of N-methyl-N′-nitro-N-nitrosoguanidine-induced in vivo elastogenicity by aqueous garlic extract. Asia Pacific J. Clin. Nutr. 2001; 10: 238–241
   PubMed Web of Science ®Google Scholar
• Asano T., Kushida H., Sadakane C., Ishihara K., Wakui Y., Yanagisawa T., Kimura M., Kamei H., Yoshida T. Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities. Biol. Pharm. Bull. 2001; 24: 678–682
   PubMed Web of Science ®Google Scholar
• Astrup A. V. Licorice-induced high blood pressure. Ugeskrift for Laeger 2001; 163: 7284–7285
   PubMedGoogle Scholar
• Backman J. T., Maenpaa J., Belle D. J., Wrighton S. A., Kivisto K. T., Neuvonen P. J. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Clin. Pharmacol. Ther. 2000; 67: 382–390
   PubMed Web of Science ®Google Scholar
• Bae E. A., Han M. J., Choo M. K., Park S. Y., Kim D. H. Metabolism of 20(S)- and 20(R)-ginsenoside R-g3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 2002; 25: 58–63
   PubMed Web of Science ®Google Scholar
• Bai Y. F., Xu H. Protective action of piperine against experimental gastric ulcer. Chung-Kuo Yao Li Hsueh Pao—Acta Pharmacol. Sinica 2000; 21: 357–359
   PubMed Web of Science ®Google Scholar
• Bailey D. G., Spence J. D., Munoz C., Arnold J. M. O. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268–269
   PubMed Web of Science ®Google Scholar
• Bailey D. G., Malcolm J., Arnold O., Spence J. D. Grapefruit juice‐drug interactions. Br. J. Clin. Pharmacol. 1998; 46: 101–110
   PubMed Web of Science ®Google Scholar
• Bailey D. G., Dresser G. R., Kreeft J. H., Munoz C., Freeman D. J., Bend J. R. Grapefruit–felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin. Pharmacol. Ther. 2000; 68: 468–477
   PubMed Web of Science ®Google Scholar
• Bajad S., Bedi K. L., Singla A. K., Johri R. K. Antidiarrhoeal activity of piperine in mice. Planta Med. 2001a; 67: 284–287
   PubMed Web of Science ®Google Scholar
• Bajad S., Bedi K. L., Singla A. K., Johri R. K. Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Med. 2001b; 67: 176–179
   PubMed Web of Science ®Google Scholar
• Bano G., Amla V., Raina R. K., Zutshi U., Chopra C. L. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med. 1987; 53: 568–569
   PubMed Web of Science ®Google Scholar
• Bano G., Raina R. K., Zutshi U., Bedi K. L., Johri R. K., Sharma S. C. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur. J. Clin. Pharmacol. 1991; 41: 615–617
   PubMed Web of Science ®Google Scholar
• Barnes J., Anderson L. A., Phillipson J. D. St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 2001; 53: 583–600
   PubMed Web of Science ®Google Scholar
• Becquemont L., Verstuyft C., Kerb R., Brinkmann U., Lebot M., Jaillon P., Funck-Brentano C. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin. Pharmacol. Ther. 2001; 70: 311–316
   PubMed Web of Science ®Google Scholar
• Bertz R. J., Granneman G. R. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet. 1997; 32: 210–258
   PubMed Web of Science ®Google Scholar
• Biffignandi P. M., Bilia A. R. The growing knowledge of St. John's wort (Hypericum perforatum L) drug interactions and their clinical significance. Curr. Ther. Res. 2000; 61: 389–394
   Web of Science ®Google Scholar
• Bocker D., Breithardt G. Induction of arrhythmia by licorice abuse. Zeitschrift fur Kardiologie 1991; 80: 389–391
   PubMedGoogle Scholar
• Boek-Dohalska L., Hodek P., Sulc M., Stiborova M. Alpha-naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP 3A6. Chem-Biol. Interact. 2001; 138: 85–106
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Sesardic D., Murray B. P., Edwards R. J., Singleton A. M., Rich K. J., Murray S., de la Torre R., Segura J., Pelkonen O., Pasanen M., Kobayashi S., Zhi-guang T., Davies D. S. Species variation in the response of the cytochrome P450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica 1990; 20: 1139–1161
   PubMed Web of Science ®Google Scholar
• Borek C. Antioxidant health effects of aged garlic extract. J. Nutr. 2001; 1010S–1015S
   Google Scholar
• Borrie M., Meunier V., Berger Y., Fabre G. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J. Pharmacol. Exp. Ther. 1996; 277: 321–332
   PubMed Web of Science ®Google Scholar
• Bourrie M., Meunier V., Berger Y., Fabre G. Cytochrome p450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J. Pharmacol. Exp. Ther. 1996; 277: 321–332
   PubMed Web of Science ®Google Scholar
• Bray B. J., Perry N. B., Menkes D. B., Rosengren R. J. St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. Toxicol. Sci. 2002; 66: 27–33
   PubMed Web of Science ®Google Scholar
• Breidenbach T., Kliem V., Burg M., Radermacher J., Hoffmann M. W., Klempnauer J. Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum). Transplantation 2000; 69: 2229–2230
   PubMed Web of Science ®Google Scholar
• Brockmoller J., Roots I. Assessment of liver metabolic function—clinical implications. Clin. Pharmacokinet. 1994; 27: 216–248
   PubMed Web of Science ®Google Scholar
• Bu-Abbas A., Clifford M. N., Walker R., Ioannides C. Modulation of hepatic cytochrome P450 activity and carcinogen bioactivation by black and decaffeinated black tea. Environ. Toxicol. Pharmacol. 1999; 7: 41–47
   PubMed Web of Science ®Google Scholar
• Budzinski J. W., Foster B. C., Vandenhoek S., Arnason J. T. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7: 273–282
   PubMed Web of Science ®Google Scholar
• Burchell B., Brierley C. H., Monaghan G., Clarke D. J. The structure and function of the UDP-glucuronosyltransferase gene family. Adv. Pharmacol. 1998; 42: 335–338
   PubMedGoogle Scholar
• Burstein A. H., Horton R. L., Dunn T., Alfaro R. M., Piscitelli S. C., Theodore W. Lack of effect of St. John's wort on carbamazepine pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. 2000; 68: 605–612
   PubMed Web of Science ®Google Scholar
• Canivenc-Lavier M. C., Bentejac M., Miller M. L., Leclerc J., Siess M. H., Latruffe N., Suschetet M. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver. Toxicol. Appl. Pharmacol. 1996; 136: 348–353
   PubMed Web of Science ®Google Scholar
• Carrillo J. A., Christensen M., Ramos S. I., Alm C., Dahl M. L., Benitez J., Bertilsson L. Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther. Drug Monitor. 2000; 22: 409–417
   PubMed Web of Science ®Google Scholar
• Chan T. Y. Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann. Pharmacother. 2001; 35: 501–504
   PubMed Web of Science ®Google Scholar
• Chan W. K., Nguyen L. T., Miller V. P., Harris R. Z. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci. 1998; 62: 135–142
   Web of Science ®Google Scholar
• Chang T. K. H., Chen J., Benetton S. A. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab. Dispos. 2002; 30: 378–384
   PubMed Web of Science ®Google Scholar
• Chen Z. N. Recent progress in the study of anti-PAF (platelet activating factor) constituents of medicinal herbs. Chung-Kuo Chung Yao Tsa Chih—China J. Chin. Mater. Med. 1993; 18: 323–326
   Google Scholar
• Chen M. F., Shimada F., Kato H., Yano S., Kanaoka M. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Endocrinol. Jpn 1990; 37: 331–341
   PubMedGoogle Scholar
• Chen M. F., Shimada F., Kato H., Yano S., Kanaoka M. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol. Jpn 1991; 38: 167–174
   PubMedGoogle Scholar
• Chen L. S., Bondoc F. Y., Lee M. J., Hussin A. H., Thomas P. E., Yang C. S. Induction of CYP1A2 by tea in rats. Drug Metab. Dispos. 1996; 24: 529–533
   PubMed Web of Science ®Google Scholar
• Chen X. G., Liu H. Y., Lei X. H., Fu Z. D., Li Y., Tao L. H., Han R. Cancer chemopreventive and therapeutic activities of red ginseng. J. Ethnopharmacol. 1998; 60: 71–78
   PubMed Web of Science ®Google Scholar
• Cheng T. O. Warfarin danshen interaction. Ann. Thorac. Surg. 1999; 67: 894
   PubMed Web of Science ®Google Scholar
• Chi J. G. Cancer chemoprevention of INSAM (Ginseng)—Foreword. J. Korean Med. Sci. 2001; 16: S1
   PubMed Web of Science ®Google Scholar
• Chi J. D., Franklin M. Determination of hypericin in plasma by high-performance liquid chromatography. J. Chromatogr. B 1999; 724: 195–198
   PubMed Web of Science ®Google Scholar
• Choudhri S. H., Gallicano K., Fosterm B. A study of pharmacokinetic interactions between garlic supplements and ritonavir in healthy volunteers (abstract 1637). The 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. American Society for Microbiology, Washington, DC 2000
   Google Scholar
• Ciolino H. P., Yeh G. C. The flavonoid galangin is an inhibitor of CYP1A1 activity and agonist/antagonist of the aryl hydrocarbon receptor. Br. J. Cancer 1999; 79: 1340–1346
   PubMed Web of Science ®Google Scholar
• Ciolino H. P., Daschner P. J., Yeh G. C. Dietary flavonols quercetin and kaempferol are ligands of aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999; 340: 715–722
   PubMed Web of Science ®Google Scholar
• Ciolino H. P., Wang T. T. Y., Yeh G. C. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. 1998; 58: 2754–2760
   PubMed Web of Science ®Google Scholar
• Clarke S. E. In vitro assessment of human cytochrome P450. Xenobiotica 1998; 28: 1167–1202
   PubMed Web of Science ®Google Scholar
• Colombo G., Agabio R., Lobina C., Reali R., Morazzoni P., Bombardelli E., Gessa G. L. Salvia miltiorrhiza extract inhibits alcohol absorption, preference, and discrimination in Prats. Alcohol 1999; 18: 65–70
   PubMed Web of Science ®Google Scholar
• Connolly J. D., Hill R. A. Triterpenoids. Natl Product. Rep. 1997; 14: 661–679
   Web of Science ®Google Scholar
• Crespi C. L., Miller V. P. The use of heterologously expressed drug metabolizing enzymes—state of the art and prospects for the future. Pharmacol. Ther. 1999; 84: 121–131
   PubMed Web of Science ®Google Scholar
• Crespi C. L., Penman B. W. Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug–drug interactions. Adv. Pharmacol. 1997; 43: 171–188
   PubMedGoogle Scholar
• Dalvi R. R. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol. Lett. 1992; 60: 299–305
   PubMed Web of Science ®Google Scholar
• Dalvi R. R., Dalvi P. S. Comparison of the effects of piperine administered intragastrically and intraperitoneally on the liver and liver mixed-function oxidases in rats. Drug Metab. Drug. Interact. 1991a; 9: 23–30
   PubMedGoogle Scholar
• Dalvi R. R., Dalvi P. S. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats. Drug Chem. Toxicol. 1991b; 14: 219–229
   PubMed Web of Science ®Google Scholar
• Davis E. A., Morris D. J. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol. Cell. Endocrinol. 1991; 78: 1–6
   PubMed Web of Science ®Google Scholar
• Deyama T., Nishibe S., Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol. Sinica 2001; 22: 1057–1070
   PubMed Web of Science ®Google Scholar
• D'Hooge R., Pei Y. Q., Raes A., Lebrun P., van Bogaert P. P., de Deyn P. P. Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittel-Forschung 1996; 46: 557–560
   PubMed Web of Science ®Google Scholar
• Dierks E. A., Stams K. R., Lim H. K., Cornelius G., Zhang H. L., Ball S. E. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab. Dispos. 2001; 29: 23–29
   PubMed Web of Science ®Google Scholar
• Dixon R. A., Steele C. Flavonoids and isoflavonoids—gold mine for metabolic engineering. Trends Plant Sci. 1999; 4: 394–400
   PubMed Web of Science ®Google Scholar
• Doostdar H., Burke M. D., Mayer R. T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000; 144: 31–38
   PubMed Web of Science ®Google Scholar
• Dresser G. K., Spence J. D., Bailey D. G. Pharmacokinetic–pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet. 2000; 38: 41–57
   PubMed Web of Science ®Google Scholar
• Ducharme M. P., Warbasse L. H., Edwards D. J. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther. 1995; 57: 485–491
   PubMed Web of Science ®Google Scholar
• Durr D., Stieger B., Kullak-Ublick G. A., Rentsch K. M., Steinert H. C., Meier P. J., Fattinger K. St John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 2000; 68: 598–604
   PubMed Web of Science ®Google Scholar
• Dwyer J. Overview: dietary approaches for reducing cardiovascular disease risks. J. Nutr. 1995; 125: 6566–6572
   Google Scholar
• Eddershaw P. J., Dickins M. Advances in in vitro drug metabolism screening. Pharm. Sci. Technol. Today 1999; 2: 13–19
   PubMedGoogle Scholar
• Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R., Delbanco T. L. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N. Engl. J. Med. 1993; 328: 246–252
   PubMed Web of Science ®Google Scholar
• Ekins S. Past, present, and future applications of precision-cut liver slices for in vitro xenobiotic metabolism. Drug Metab. Rev. 1996; 28: 591–623
   PubMed Web of Science ®Google Scholar
• Ekins S., Erickson J. A. A pharmacophore for human pregnane X receptor ligands. Drug Metab. Dispos. 2002; 30: 96–99
   PubMed Web of Science ®Google Scholar
• Ekins S., Schuetz E. The PXR crystal structure: the end of the beginning. Trends Pharmacol. Sci. 2002; 23: 49–50
   PubMed Web of Science ®Google Scholar
• Ekins S., Wrighton S. A. Application of in silico approaches to predicting drug–drug interactions. J. Pharmacol. Toxicol. Methods 2001; 45: 65–69
   PubMed Web of Science ®Google Scholar
• Ekins S., Ring B. J., Grace J., McRobie-Belle D. J., Wrighton S. A. Present and future in vitro approaches for drug metabolism. J. Pharmacol. Toxicol. Methods 2000; 44: 313–324
   PubMed Web of Science ®Google Scholar
• Elvin-Lewis M. Should we be concerned about herbal remedies. J. Ethnopharmacol. 2001; 75: 141–164
   PubMed Web of Science ®Google Scholar
• Erdelmeier C. A. J. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsychiatry 1998; 31S: 2–6
   Web of Science ®Google Scholar
• Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann. Int. Med. 2002; 136: 42–53
   PubMed Web of Science ®Google Scholar
• Evans A. M. Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Ther. Drug Monitor. 2000; 22: 131–136
   PubMed Web of Science ®Google Scholar
• Ferrari P., Sansonnens A., Dick B., Frey F. J. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension 2001; 38: 1330–1336
   PubMed Web of Science ®Google Scholar
• Ferrero J. L., Brendel K. Liver slices as a model in drug metabolism. Adv. Pharmacol. 1997; 43: 131–169
   PubMedGoogle Scholar
• Fitzsimmons M. E., Collins J. M. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P450 3A4: potential contribution to high first-pass metabolism. Drug Metab. Dispos. 1997; 25: 256–266
   PubMed Web of Science ®Google Scholar
• Foster B. C., Foster M. S., Vandenhoek S., Krantis A., Budzinski J. W., Arnason J. T., Gallicano K. D., Choudri S. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J. Pharm. Pharm. Sci. 2001; 4: 176–184
   PubMed Web of Science ®Google Scholar
• Fox E., Murphy R. F., McCully C. L., Adamson P. C. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates. Cancer Chemother. Pharmacol. 2001; 47: 41–44
   PubMed Web of Science ®Google Scholar
• Frantz D. J., Hughes B. G., Nelson D. R., Murray B. K., Christensen M. J. Cell cycle arrest and differential gene expression in HT-29 cells exposed to an aqueous garlic extract. Nutr. Cancer 2000; 38: 255–264
   PubMed Web of Science ®Google Scholar
• Frye R. F., Matzke G. R., Adedoyin A., Porter J. A., Branch R. A. Validation of the five-drug Pittsburgh cocktail approach for assessment of selective regulation of drug-metabolizing enzymes. Clin. Pharmacol. Ther. 1997; 62: 365–376
   PubMed Web of Science ®Google Scholar
• Fugh-Berman A. Herbal medicinals: selected clinical considerations, focusing on known or potential drug–herb interactions. Arch. Int. Med. 1999; 159: 1957–1958
   PubMed Web of Science ®Google Scholar
• Fugh-Berman A. Herb–drug interactions. Lancet 2000; 355: 134–138
   PubMed Web of Science ®Google Scholar
• Fugh-Berman A., Ernst E. Herb–drug interactions: review and assessment of report reliability. Br. J. Clin. Pharmacol. 2001; 52: 587–595
   PubMed Web of Science ®Google Scholar
• Fujisawa Y., Sakamoto M., Matsushita M., Fujita T., Nishioka K. Glycyrrhizin inhibits the lytic pathway of complement-possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis. Microbiol. Immunol. 2000; 44: 799–804
   PubMed Web of Science ®Google Scholar
• Fujita K., Kamataki T. Screening of organosulfur compounds as inhibitors of human CYP2A6. Drug Metab. Dispos. 2001; 29: 983–989
   PubMed Web of Science ®Google Scholar
• Fukuda K., Ohta T., Oshima Y., Ohashi N., Yoshikawa M., Yamazoe Y. Specific inhibitors in grapefruit juice: furanocoumarin dimers as components of drug interaction. Pharmacogenetics 1997; 5: 391–396
   Google Scholar
• Fukutake M., Miura N., Yamamoto M., Fukuda K., Iijima O., Ishikawa H., Kubo M., Okada M., Komatsu Y., Sasaki H., Wakabayashi K., Ishige A., Amagaya S. Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats. Cancer Lett. 2000; 157: 9–14
   PubMed Web of Science ®Google Scholar
• Fukutake M., Yokota S., Kamamura H., Iizuka A., Amagaya S., Fukuda K., Komatsu Y. Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol. Pharm. Bull. 1998; 21: 814–817
   PubMed Web of Science ®Google Scholar
• Furutsu M., Koyama Y., Kusakabe M., Takahashi S. Preventive effect of the extract of Du-zhong (Tochu) leaf and ginseng root on acute toxicity of chlorpyrifos. Jpn. J. Toxicol. Environ. Health 1997; 43: 92–100
   Web of Science ®Google Scholar
• Galati G., Teng S., Moridani M. Y., Chan T. S., O'Brien P. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metab. Drug. Interact. 2000; 17: 311–349
   PubMedGoogle Scholar
• Galluzzi S., Zanetti O., Binetti G., Trabucchi M., Frisoni G. B. Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba. J. Neurol. Neurosurg. Psychiatr. 2000; 68: 679–680
   PubMed Web of Science ®Google Scholar
• Gasper J., Laires A., Monteiro M., Laureano O., Ramos E., Rueff J. Quercetin and the mutagenicity of wines. Mutagenesis 1993; 8: 51–55
   PubMed Web of Science ®Google Scholar
• Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann. Int. Med. 2001; 135: 594–600
   PubMed Web of Science ®Google Scholar
• Goodwin B., Moore L. B., Stoltz C. M., McKee D. D., Kliewer S. A. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 2001; 60: 427–431
   PubMed Web of Science ®Google Scholar
• Gordon P. B., Holen I., Seglen P. O. Protection by naringin and some other flavonoids of hepatocytic autophagy endocytosis against inhibition by okadaic acid. J. Biol. Chem. 1995; 270: 5830–5838
   PubMed Web of Science ®Google Scholar
• Guo L. Q., Taniguchi M., Chen Q. Y., Baba K., Yamazoe Y. Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of Umbelliferous or Citrus crude drugs and their relative prescriptions. Jpn. J. Pharmacol. 2001; 85: 399–408
   PubMedGoogle Scholar
• Gupta S. K., Bansal P., Bhardwaj R. K., Velpandian T. Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharm. Res. 2000; 41: 657–662
   Web of Science ®Google Scholar
• Gupta S. K., Velpandian T., Sengupta S., Mathur P., Sapra P. Influence of piperine on nimesulide induced antinociception. Phytother. Res. 1998; 12: 266–269
   Web of Science ®Google Scholar
• Guyonnet D., Belloir C., Suschetet M., Siess M. H., Le Bon A. M. Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation. Mut. Res. 2000; 466: 17–26
   PubMed Web of Science ®Google Scholar
• Guyonnet D., Belloir C., Suschetet M., Siess M. H., Le Bon A. M. Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mut. Res. 2001; 495: 135–145
   PubMed Web of Science ®Google Scholar
• Haber D., Siess M. H., De Waziers I., Beaune P., Suschetet M. Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphides. Xenobiotica 1994; 24: 169–182
   PubMed Web of Science ®Google Scholar
• Haber D., Siess M. H., Canivenc-Lavier M. C., Le Bon A. M., Suschetet M. Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes. J. Toxicol. Environ. Health 1995; 44: 423–434
   PubMed Web of Science ®Google Scholar
• Halpert J. R., Guengerich F. P., Bend J. R., Correia M. A. Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol. 1994; 125: 163–175
   PubMed Web of Science ®Google Scholar
• Han B. H., Han Y. N., Park M. H., Lee E. S., Suh D. Y. Chemistry and biochemistry of ginseng components: ginsenosides and antioxidants. Emerging Drugs: Molecular Aspects of Asian Medicines. 2001; 387–398
   Google Scholar
• Hao N. J., Huang M. P., Lee H. Structure–activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline. Mutat. Res. 1995; 328: 183–191
   PubMed Web of Science ®Google Scholar
• Hasegawa T., Yamaki K., Muraoka I., Nadai M., Takagi K., Nabeshima T. Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin. Antimicrob. Agents Chemother. 1995; 39: 2135–2137
   PubMed Web of Science ®Google Scholar
• Hatano T., Fukuda T., Liu Y. Z., Noro T., Okuda T. Phenolic constituents of licorice. IV. Correlation of phenolic constituents and licorice specimens from various sources, and inhibitory effects of licorice extracts on xanthine oxidase and monoamine oxidase. Yakugaku Zasshi—J. Pharmaceutical Soc. Jpn 1991a; 111: 311–321
   PubMed Web of Science ®Google Scholar
• Hatano T., Fukuda T., Miyase T., Noro T., Okuda T. Phenolic constituents of licorice. III. Structures of glicoricone and licofuranone, and inhibitory effects of licorice constituents on monoamine oxidase. Chem. Pharm. Bull. 1991b; 39: 1238–1243
   PubMed Web of Science ®Google Scholar
• He K., Iyer K. R., Hayes R. N., Sinz M. W., Woolf T. F., Hollenberg P. F. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res. Toxicol. 1998; 11: 252–259
   PubMed Web of Science ®Google Scholar
• Heck A. M., DeWitt B. A., Lukes A. L. Potential interactions between alternative therapies and warfarin. Am. J. Health-System Pharm. 2000; 57: 1221–1227
   PubMed Web of Science ®Google Scholar
• Helsby N. A., Williams J., Kerr D., Gescher A., Chipman J. K. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. Xenobiotica 1997; 27: 587–596
   PubMed Web of Science ®Google Scholar
• Henderson G. L., Harkey M. R., Gershwin M. E., Hackman R. M., Stern J. S., Stresser D. M. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. 1999; 65: PL209–PL214
   PubMed Web of Science ®Google Scholar
• Henderson M. C., Miranda C. L., Stevens J. F., Deinzer M. L., Buhler D. R. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 2000; 30: 235–251
   PubMed Web of Science ®Google Scholar
• Hengstler J. G., Utesch D., Steinberg P., Platt K., Diener B., Ringel M., Swales N., Fischer T., Biefang K., Gerl M., Bottger T., Oesch F. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab. Rev. 2000; 32: 81–118
   PubMed Web of Science ®Google Scholar
• Hennessy M., Kelleher D., Spiers J. P., Barry M., Kavanagh P., Back D., Mulcahym F., Feely J. St John's Wort increases expression of P-glycoprotein: implications for drug interactions. Br. J. Clin. Pharmacol. 2002; 53: 75–82
   PubMed Web of Science ®Google Scholar
• Hirsch K., Danilenko M., Giat J., Miron T., Rabinkov A., Wilchek M., Mirelman D., Levy J., Sharoni Y. Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr. Cancer 2000; 38: 245–254
   PubMed Web of Science ®Google Scholar
• Ho P. C., Saville D. J., Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J. Pharm. Pharm. Sci. 2001; 4: 217–227
   PubMed Web of Science ®Google Scholar
• Hodek P., Trefil P., Stiborova M. Flavonoids–potent and versatile biologically active compounds interacting with cytochromes P450. Chem-Biol. Interact. 2002; 139: 1–21
   PubMed Web of Science ®Google Scholar
• Hollman P. C., Katan M. B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 1997; 51: 305–310
   PubMed Web of Science ®Google Scholar
• Homma M., Oka K., Niitsuma T., Itoh H. A novel 11 beta-hydroxysteroid dehydrogenase inhibitor contained in saiboku-to, a herbal remedy for steroid-dependent bronchial asthma. J. Pharm. Pharmacol. 1994; 46: 305–309
   PubMed Web of Science ®Google Scholar
• Homma M., Oka K., Ikeshima K., Takahashi N., Niitsuma T., Fukuda T., Itoh H. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J. Pharm. Pharmacol. 1995; 47: 687–692
   PubMed Web of Science ®Google Scholar
• Hosea N. A., Miller G. H., Guengerich F. P. Elucidation of distinct ligand binding sites for cytochrome P450 3A4. Biochemistry 2000; 39: 5929–5939
   PubMed Web of Science ®Google Scholar
• Houston J. B. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 1994; 47: 1469–1479
   PubMed Web of Science ®Google Scholar
• Houston J. B., Kenworthy K. E. In vitro–in vivo scaling of CYP kinetic data not consistent with the classical Michaelis–Menten model. Drug Metab. Dispos. 2000; 28: 246–254
   PubMed Web of Science ®Google Scholar
• Hundal M. K., Jnagal S., Khanduja K. L., Ganguly N. K. Modulation of carcinogen-metabolizing enzymes by gallic acid and its synthetic analogue propylgallate in mice. J. Clin. Biochem. Nutr. 1995; 19: 147–153
   Web of Science ®Google Scholar
• Hundertmark S., Buhler H., Rudolf M., Weitzel H. K., Ragosch V. Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J. Endocrinol. 1997; 155: 171–180
   PubMed Web of Science ®Google Scholar
• Hunter J., Hirst B. H. Intestinal secretion of drugs—the role of p-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv. Drug Deliv. Rev. 1997; 25: 129–157
   Web of Science ®Google Scholar
• Ingram K. D., Dragosavac G. B., Benner K. G., Flora K. D. Risks of drug interactions with St. John's Wort. Am. J. Gastroenterol. 2000; 95: 3323–3324
   PubMed Web of Science ®Google Scholar
• Ishihara K., Kushida H., Yuzurihara M., Wakui Y., Yanagisawa T., Kamei H., Ohmori S., Kitada M. Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica. J. Pharm. Pharmacol. 2000; 52: 1023–1029
   PubMed Web of Science ®Google Scholar
• Ito K., Iwatsubo T., Kanamitsu S., Nukajima Y., Sugiyama Y. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Ann. Rev. Pharmacol. Toxicol. 1998a; 38: 461–499
   PubMed Web of Science ®Google Scholar
• Ito K., Iwatsubo T., Kanamitsu S., Ueda K., Suzuki H., Sugiyama Y. Prediction of pharmacokinetic alterations caused by drug–drug interactions: metabolic interaction in the liver. Pharmacol. Rev. 1998b; 50: 387–411
   PubMed Web of Science ®Google Scholar
• Iyer L. Inherited variations in drug-metabolizing enzymes: significance in clinical oncology. Mol. Diag. 1999; 4: 327–333
   PubMedGoogle Scholar
• Izzat M. B., Yim A. P. C., El-Zufari M. H. A taste of Chinese medicine!. Ann. Thorac. Surg. 1998; 66: 941–942
   PubMed Web of Science ®Google Scholar
• Izzo A. A., Ernst E. Interactions between herbal medicines and prescribed drugs—a systematic review. Drugs 2001; 61: 2163–2175
   PubMed Web of Science ®Google Scholar
• Izzo A. A., Capasso R., Pinto L., Di Carlo G., Mascolo N., Capasso F. Effect of vanilloid drugs on gastrointestinal transit in mice. Br. J. Pharmacol. 2001; 132: 1411–1416
   PubMed Web of Science ®Google Scholar
• Janetzky K., Morreale A. P. Probable interaction between warfarin and ginseng. Am. J. Health-Syst. Pharm. 1997; 54: 692–693
   PubMed Web of Science ®Google Scholar
• Jeong H. G. Suppression of constitutive and inducible cytochrome P450 gene expression by alpha-hederin in mice. Biochem. Mol. Biol. Intl 1998; 46: 1019–1026
   PubMedGoogle Scholar
• Jeong H. G. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol. Lett. 1999; 105: 215–222
   PubMed Web of Science ®Google Scholar
• Jeong H. G., Lee S. S. Suppressive effects of alpha-hederin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated murine Cypla-1 expression in the mouse hepatoma Hepa-1c1c7 cells. Cancer Lett. 1999; 138: 131–137
   PubMed Web of Science ®Google Scholar
• Jin J. X., Baillie T. A. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chem. Res. Toxicol. 1997; 10: 318–327
   PubMed Web of Science ®Google Scholar
• Johne A., Brockmoller J., Bauer S., Maurer A., Langheinrich M., Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin. Pharmacol. Ther. 1999; 66: 338–345
   PubMed Web of Science ®Google Scholar
• Johne A., Schmider J., Brockmoller J., Stadelmann A. M., Stormer E., Bauer S., Scholler G., Langheinrich M., Roots I. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's Wort (Hypericum perforatum). J. Clin. Psychopharmacol. 2002; 22: 46–54
   PubMed Web of Science ®Google Scholar
• Jones B. D., Runikis A. M. Interaction of ginseng with phenelzine. J. Clin. Psychopharmacol. 1987; 7: 201–202
   PubMed Web of Science ®Google Scholar
• Jurgenliemk G., Nahrstedt A. Phenolic compounds from Hypericum perforatum. Planta Med. 2002; 68: 88–91
   PubMed Web of Science ®Google Scholar
• Kaminsky L. S., Zhang Z. Y. Human P450 metabolism of warfarin. Pharmacol. Ther. 1997; 73: 67–74
   PubMed Web of Science ®Google Scholar
• Kane G. C., Lipsky J. J. Drug–grapefruit juice interactions. Mayo Clin. Proc. 2000; 75: 933–942
   PubMed Web of Science ®Google Scholar
• Kang C., Tsai S. J., Lee H. Quercetin inhibits benzo[a]pyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 expression. Nutr. Cancer 1999; 35: 175–179
   PubMed Web of Science ®Google Scholar
• Kang J. J., Chen Y. C., Kuo W. C., Chen T., Cheng Y. W., Kuo M. L., Ueng T. H. Modulation of microsomal cytochrome P450 by Scutellariae Radix and Gentianae scabrae Radix in rat liver. Am. J. Chin. Med. 1996; 24: 19–29
   PubMed Web of Science ®Google Scholar
• Kang M. H., Won S. M., Park S. S., Kim S. G., Novak R. F., Kim N. D. Piperine effects on the expression of P4502E1, P4502B and P4501A in rat. Xenobiotica 1994; 24: 1195–1204
   PubMed Web of Science ®Google Scholar
• Kent U. M., Aviram M., Rosenblat M., Hollenberg P. F. The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Drug Metab. Dispos. 2002; 30: 709–715
   PubMed Web of Science ®Google Scholar
• Kim H. J., Chun Y. J., Park J. D., Kim S. I., Roh J. K., Jeong T. C. Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Med. 1997; 63: 415–418
   PubMed Web of Science ®Google Scholar
• Kim A. E., Dintaman J. M., Waddell D. S. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. J. Pharmacol. Exp. Ther. 1998; 286: 143–149
   Web of Science ®Google Scholar
• Kim B. R., Kim D. H., Park R., Kwon K. B., Ryu D. G., Kim Y. C., Kim N. Y., Jeong S., Kang B. K., Kim K. S. Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B-1 oxidizing cytochrome P450 enzymes. Planta Med. 2001; 67: 396–399
   PubMed Web of Science ®Google Scholar
• Kishimoto R., Ueda M., Yoshinaga H., Goda K., Park S. S. Combined effects of ethanol and garlic on hepatic ethanol metabolism in mice. J. Nutr. Sci. Vitaminol. 1999; 45: 275–286
   PubMed Web of Science ®Google Scholar
• Kobayashi K., Urashima K., Shimada N., Chiba K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem. Pharmacol. 2002; 63: 889–896
   PubMed Web of Science ®Google Scholar
• Kohn M. C., Walker N. J., Kim A. H., Portier C. J. Physiological modeling of a proposed mechanism of enzyme induction by TCDD. Toxicology 2001; 162: 193–208
   PubMed Web of Science ®Google Scholar
• Koul S., Koul J. L., Taneja S. C., Dhar K. L., Jamwal D. S., Singh K., Reen R. K., Singh J. Structure–activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome P450 activities. Bioorg. Med. Chem. 2000; 8: 251–268
   PubMed Web of Science ®Google Scholar
• Krieglstein J., Ausmeier F., Elabhar H., Lippert K., Welsch M., Rupalla K., Henrichnoack P. Neuroprotective effects of Ginkgo biloba constituents. Eur. J. Pharm. Sci. 1995; 3: 39–48
   Web of Science ®Google Scholar
• Kroemer H. K., Klotz U. Glucuronidation of drugs: a re-evaluation of the pharmacological significance of the conjugates and modulation factors. Clin. Pharmacokinet. 1992; 23: 292–310
   PubMed Web of Science ®Google Scholar
• Kwon K. B., Yoo S. J., Ryu D. G., Yang J. Y., Rho H. W., Kim J. S., Park J. W., Kim H. R., Park B. H. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol. 2002; 63: 41–47
   PubMed Web of Science ®Google Scholar
• Lacailledubois M. A., Wagner H. A review of the biological and pharmacological activities of saponins. Phytomedicine 1996; 2: 363–386
   PubMed Web of Science ®Google Scholar
• Lahiri-Chatterjee M., Katiyar S. K., Mohan R. R., Agarwal R. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res. 1999; 59: 622–632
   PubMed Web of Science ®Google Scholar
• Lautraite S., Musonda A. C., Doehmer J., Edwards G., Chipman J. K. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1. Mutagenesis 2002; 17: 45–53
   PubMed Web of Science ®Google Scholar
• LeCluyse E. L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci. 2001; 13: 343–368
   PubMed Web of Science ®Google Scholar
• Lee P. I., Lawrence J. D. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19
   Google Scholar
• Lee S. E., Campbell B. C., Molyneux R. J., Hasegawa S., Lee H. S. Inhibitory effects of naturally occurring compounds on aflatoxin B-1 biotransformation. J. Agric. Food Chem. 2001; 49: 5171–5177
   PubMed Web of Science ®Google Scholar
• Lee F. C., Ko J. H., Park J. K., Lee J. S. Effects of Panax ginseng on blood alcohol clearance in man. Clin. Exp. Pharmacol. Physiol. 1987; 14: 543–546
   PubMed Web of Science ®Google Scholar
• Lee Y. J., Pantuck C. B., Pantuck E. J. Effect of ginseng on plasma levels of ethanol in the rat. Planta Med. 1993; 59: 17–19
   PubMed Web of Science ®Google Scholar
• Lee H., Yeom H., Kim Y. G., Yoon C. N., Jin C., Choi J. S., Kim B. R., Kim D. H. Structure-related inhibition of human hepatic caffeine N3-demethylation by naturally occurring flavonoids. Biochem. Pharmacol. 1998; 55: 1369–1375
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. COMPACT: a structural approach to the modelling of cytochromes P450 and their interactions with xenobiotics. J. Chem. Technol. Biotechnol. 2001; 76: 237–244
   Web of Science ®Google Scholar
• Lewis D. F., Ionnides C., Parke D. V. Cytochrome P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ. Health Perspect. 1998; 106: 633–641
   PubMed Web of Science ®Google Scholar
• Li A. P. Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug–drug interactions. Adv. Pharmacol. 1997; 43: 103–130
   PubMedGoogle Scholar
• Li A. P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today 2001; 6: 357–366
   PubMed Web of Science ®Google Scholar
• Li A. P., Gorycki P. D., Hengstler J. G., Kedderis G. L., Koebe H. G., Rahmani R., de Sousas G., Silva J. M., Skett P. Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. Chem.-Biol. Interact. 1999; 121: 117–123
   PubMed Web of Science ®Google Scholar
• Liao B. S., Newmark H., Zhou R. P. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp. Neurol. 2002; 173: 224–234
   PubMed Web of Science ®Google Scholar
• Lin J. H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 1995; 23: 1008–1021
   PubMed Web of Science ®Google Scholar
• Lin J. H. Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab. Dispos. 1998; 26: 1202–1212
   PubMed Web of Science ®Google Scholar
• Lin J. H., Lu A. Y. H. Inhibition and induction of cytochrome P450 and the clinical implications. Clin. Pharmacokinet. 1998; 35: 361–390
   PubMed Web of Science ®Google Scholar
• Lin J. H., Lu A. Y. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Ann. Rev. Pharmacol. Toxicol. 2001; 41: 535–567
   PubMed Web of Science ®Google Scholar
• Lin Z., Hoult J. R., Bennett D. C., Raman A. Stimulation of mouse melanocyte proliferation by Piper nigrum fruit extract and its main alkaloid, piperine. Planta Med. 1999; 65: 600–603
   PubMed Web of Science ®Google Scholar
• Liu J., Liu Y. P., Parkinson A., Klaassen C. D. Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice. J. Pharmacol. Exp. Ther. 1995; 275: 768–774
   PubMed Web of Science ®Google Scholar
• Lo A. C., Chan K., Yeung J. H., Woo K. S. The effects of danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats. Eur. J. Drug Metab. Pharmacokinet. 1992; 17: 257–262
   PubMed Web of Science ®Google Scholar
• Loizou G. D., Cocker J. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone. Human Exp. Toxicol. 2001; 20: 321–327
   PubMed Web of Science ®Google Scholar
• Longo V., Amato G., Salvetti A., Gervasi P. G. Heterogenous effects of anthraquinones on drug-metabolizing enzymes in the liver and small intestine of rat. Chem-Biol. Interact. 2000; 126: 63–77
   PubMed Web of Science ®Google Scholar
• Lown K. S., Bailey D. G., Fontana R. J., Janardan S. K., Adair C. H., Fortlage L. A., Brown M. B., Guo W., Watkins P. B. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J. Clin. Investig. 1997; 99: 2297–2298
   PubMed Web of Science ®Google Scholar
• Lucas D., Ferrara R., Gonzalez E., Bodenez P., Albores A., Manno M., Berthou F. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 1999; 9: 377–388
   PubMedGoogle Scholar
• de Maat M. M., Hoetelmans R. M., Math t R. A., van Gorp E. C., Meenhorst P. L., Mulder J. W., Beijnen J. H. Drug interaction between St John's wort and nevirapine. AIDS 2001; 15: 420–421
   PubMed Web of Science ®Google Scholar
• Maliakal P. P., Coville P. F., Wanwimolruk S. Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J. Pharm. Pharmacol. 2001; 53: 569–577
   PubMed Web of Science ®Google Scholar
• Markowitz J. S., DeVane C. L., Boulton D. W., Carson S. W., Nahas Z., Risch S. C. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci. 2000; 66: PL133–PL139
   PubMed Web of Science ®Google Scholar
• Masimirembwa C. M., Thompson R., Andersson T. B. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery. Combinat. Chem. High Throughput Screen. 2001; 4: 245–263
   PubMed Web of Science ®Google Scholar
• Maurer A., Johne A., Bauer S. Interaction of St. John's wort extract with phenprocoumon. Eur. J. Clin. Pharmacol. 1999; 55: 22
   Google Scholar
• Mayanagi M., Nakayama S., Oguchi K. Effects of Sino-Japanese herbs in the family Compositae on the hepatic drug metabolizing enzymes and lipid peroxidation in rats. Nippon Yakurigaku Zasshi—Folia Pharmacologica Japonica 1992a; 100: 29–37
   PubMed Web of Science ®Google Scholar
• Mayanagi M., Nakayama S., Oguchi K. Effects of Sino-Japanese herbs in the family Umbelliferae on the hepatic drug metabolizing enzymes and lipid peroxidation in rats. Nippon Yakurigaku Zasshi—Folia Pharmacologica Japonica 1992b; 99: 115–121
   PubMed Web of Science ®Google Scholar
• McKenna D. J., Jones K., Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Alternat. Ther. Health Med. 2001; 7: 70–86
   PubMed Web of Science ®Google Scholar
• Meech R., Mackenzie P. I. Structure and function of uridine diphosphate glucuronosyltransferases. Clin. Exp. Pharmacol. Physiol. 1997; 24: 907–915
   PubMed Web of Science ®Google Scholar
• Miller L. G. Herbal medicinals: selected clinical considerations focusing on known or potential drug–herb interactions. Arch. Int. Med. 1998; 158: 2200–2211
   PubMed Web of Science ®Google Scholar
• Mittal R., Gupta R. L. In vitro antioxidant activity of piperine. Methods Find. Exp. Clin. Pharmacol. 2000; 22: 271–274
   PubMed Web of Science ®Google Scholar
• Mohri K., Uesawa Y. Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm. Res. 2001; 18: 177–182
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Schmider J., Wright C. E., Harmatz J. S., Shader R. I. In vitro approaches to predicting drug interactions in vivo. Biochem. Pharmacol. 1998; 55: 113–122
   PubMed Web of Science ®Google Scholar
• Moore L. B., Goodwin B., Jones S. A., Wisely G. B., Serabjit-Singh C. J., Willson T. M. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl Acad. Sci. USA 2000; 97: 7500–7502
   PubMed Web of Science ®Google Scholar
• Moschella C., Jaber B. L. Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation. Am. J. Kidney Dis. 2001; 38: 1105–1107
   PubMed Web of Science ®Google Scholar
• Mueller S. O., Stopper H., Dekant W. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome p450 enzymes—bioactivation to genotoxic metabolites. Drug Metab. Dispos. 1998; 26: 540–546
   PubMed Web of Science ®Google Scholar
• Murakami A., Kitazono Y., Jiwajinda S., Koshimizu K., Ohigashi H. Niaziminin, a thiocarbamate from the leaves of Moringa oleifera, holds a strict structural requirement for inhibition of tumor-promoter-induced Epstein–Barr virus activation. Planta Med. 1998; 64: 319–323
   PubMed Web of Science ®Google Scholar
• Murray M., Reidy G. F. Selectivity in the inhibition of mammalian cytochrome P450-by chemical agents. Pharmacol. Rev. 1990; 42: 85–101
   PubMed Web of Science ®Google Scholar
• Muto S., Fujita K., Yamazaki Y., Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 2001; 479: 197–206
   PubMed Web of Science ®Google Scholar
• Nagai T., Suzuki Y., Tomimori T., Yamada H. Antiviral activity of plant flavonoids. Biol. Pharm. Bull. 1995; 18: 295–302
   PubMed Web of Science ®Google Scholar
• Nakagawa H., Tsuta K., Kiuchi K., Senzaki H., Tanaka K., Hioki K., Tsubura A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 2001; 22: 891–897
   PubMed Web of Science ®Google Scholar
• Nakayama S., Koizumi K., Iijima K., Mayanagi M., Oguchi K. Effects of Sino-Japanese herbs in the family Labiatae on the hepatic drug metabolizing enzymes and lipid peroxidation in rats. Nippon Yakurigaku Zasshi—Folia Pharmacologica Japonica 1993; 101: 327–336
   PubMedGoogle Scholar
• Neary J. T., Bu Y. R., Hypericum L.I.1.6.0. inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res. 1999; 816: 358–363
   PubMed Web of Science ®Google Scholar
• Nebel A., Schneider B. J., Baker R. K., Kroll D. J. Potential metabolic interaction between St. John's wort and theophylline. Ann. Pharmacother. 1999; 33: 502
   PubMed Web of Science ®Google Scholar
• Newton D. J., Wang R. W., Lu A. Y. H. Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 1995; 23: 154–158
   PubMed Web of Science ®Google Scholar
• Nguyen T. D., Villard P. H., Barlatier A., Elsisi A. E., Jouve E., Duc N. M., Sauze C., Durand A., Lacarelle B. Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression. Planta Med. 2000; 66: 714–719
   PubMed Web of Science ®Google Scholar
• Nishimura N., Naora K., Hirano H., Iwamoto K. Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats. J. Pharm. Pharmacol. 1998; 50: 231–236
   PubMed Web of Science ®Google Scholar
• Nishimura N., Naora K., Hirano H., Iwamoto K. Effects of sho-saiko-to (xiao chai hu tang), a Chinese traditional medicine, on the gastric function and absorption of tolbutamide in rats. Yakugaku Zasshi—J. Pharm. Soc. Jpn 2001; 121: 153–159
   PubMed Web of Science ®Google Scholar
• Nishino H., Tokuda H., Li T., Takemura M., Kuchide M., Kanazawa M., Mou X. Y., Bu P., Takayasu J., Onozuka M., Masuda M., Satomi Y., Konoshima T., Kishi N., Baba M., Okada Y., Okuyama T. Cancer chemoprevention by ginseng in mouse liver and other organs. J. Korean Med. Sci. 2001; 16: S66–S69
   PubMed Web of Science ®Google Scholar
• Nobata S., Ohira T., Nagae H., Ushiyama T., Suzuki K., Fujita K. Licorice-induced pseudoaldosteronism in a patient with a non-functioning adrenal tumor. Hinyokika Kiyo—Acta Urologica Japonica 2001; 47: 633–635
   PubMedGoogle Scholar
• Obach R. S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther. 2000a; 294: 88–95
   PubMed Web of Science ®Google Scholar
• Obach R. S. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro–in vivo correlation. Drug Metab. Dispos. 2000b; 28: 1069–1076
   PubMed Web of Science ®Google Scholar
• Ohnishi N., Nakasako S., Okada K., Umehara S., Takara K., Nagasawa K., Yoshioka M., Kuroda K., Yokoyama T. Studies on interactions between traditional herbal and western medicines. IV: Lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats. Eur. J. Drug Metab. Pharmacokinet. 2001; 26: 129–135
   PubMed Web of Science ®Google Scholar
• Ojima M., Satoh K., Gomibuchi T., Itoh N., Kin S., Fukuchi S., Miyachi Y. The inhibitory effects of glycyrrhizin and glycyrrhetinic acid on the metabolism of cortisol and prednisolone—in vivo and in vitro studies. Nippon Naibunpi Gakkai Zasshi—Folia Endocrinol Japon 1990; 66: 584–596
   PubMedGoogle Scholar
• Olinga P., Meijer D. K. F., Slooff M. J. H., Groothuis G. M. M. Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicol. In Vitro 1998; 12
   Google Scholar
• Omiecinski C. J., Remmel R. P., Hosagrahara V. P. Concise review of the cytochrome P450s and their roles in toxicology. Toxicol. Sci. 1999; 48: 151–156
   PubMed Web of Science ®Google Scholar
• Otake Y., Walle T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metab. Dispos. 2002; 30: 103–105
   PubMed Web of Science ®Google Scholar
• Owen A., Pirmohamed M., Tettey J. N., Morgan P., Chadwick D., Park B. K. Carbamazepine is not a substrate for P-glycoprotein. Br. J. Clin. Pharmacol. 2001; 51: 345–349
   PubMed Web of Science ®Google Scholar
• Palmer J. L., Scott R. J., Gibson A., Dickins M., Pleasance S. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A). Br. J. Clin. Pharmacol. 2001; 52: 555–561
   PubMed Web of Science ®Google Scholar
• Paolini M., Barillari J., Broccoli M., Pozzetti L., Perocco P., Cantelli-Forti G. Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Lett. 1999; 145: 35–42
   PubMed Web of Science ®Google Scholar
• Paolini M., Pozzetti L., Sapone A., Cantelli-Forti G. Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases. Life Sci. 1998; 62: 571–582
   PubMed Web of Science ®Google Scholar
• Parrish A. R., Gandolfi A. J., Brendel K. Precision-cut tissue slices—applications in pharmacology and toxicology. Life Sci. 1995; 57: 1887–1901
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Maenpaa J., Taavitsainen P., Rautio A., Raunio H. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 1998; 28: 1203–1253
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Myllynen P., Taavitsainen P., Boobis A. R., Watts P., Lake B. G., Price R. J., Renwick A. B., Gomez-Lechon M. J., Castell J. V., Ingelman-Sundberg M., Hidestrand M., Guillouzo A., Corcos L., Goldfarb P. S., Lewis D. F. V. Carbamazepine: a ‘blind’ assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems. Xenobiotica 2001; 31: 321–343
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Rautio A., Raunio H., Pasanen M. CYP2A6: a human coumarin 7-hydroxylase. Toxicology 2000; 144: 139–147
   PubMed Web of Science ®Google Scholar
• Pianetti S., Guo S. Q., Kavanagh K. T., Sonenshein G. E. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 2002; 62: 652–655
   PubMed Web of Science ®Google Scholar
• Piscitelli S. C., Burstein A. H., Chaitt D., Alfaro R. M., Falloon J. Indinavir concentrations and St. John's wort. Lancet 2000; 355: 547–548
   PubMed Web of Science ®Google Scholar
• Piscitelli S. C., Burstein A. H., Welden N., Gallicano K. D., Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin. Infect. Dis. 2001; 34: 234–238
   PubMed Web of Science ®Google Scholar
• Piver B., Berthou F., Dreano Y., Lucas D. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol. Lett. 2001; 125: 83–91
   PubMed Web of Science ®Google Scholar
• Premdas P. D., Bowers R. J., Forkert P. G. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone. J. Pharmacol. Exp. Ther. 2000; 293: 1112–1120
   PubMed Web of Science ®Google Scholar
• Quattrochi L. C., Guzelian P. S. CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab. Dispos. 2001; 29: 615–622
   PubMed Web of Science ®Google Scholar
• Rahman K. Historical perspective on garlic and cardiovascular disease. J. Nutr. 2001; 131: 977S–979S
   PubMed Web of Science ®Google Scholar
• Ramaiah S. K., Apte U., Mehendale H. M. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab. Dispos. 2001; 29: 1088–1095
   PubMed Web of Science ®Google Scholar
• Ramchandani V. A., Bosron W. F., Li T. K. Research advances in ethanol metabolism. Pathol. Biol. 2001; 49: 676–682
   PubMed Web of Science ®Google Scholar
• Reddy B. S., Rao C. V., Rivenson A., Kelloff G. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res. 1993; 53: 3493–3498
   PubMed Web of Science ®Google Scholar
• Reen R. K., Jamwal D. S., Taneja S. C., Koul J. L., Dubey R. K., Wiebel F. J., Singh J. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem. Pharmacol. 1993; 46: 229–238
   PubMed Web of Science ®Google Scholar
• Reen R. K., Roesch S. F., Kiefer F., Wiebel F. J., Singh J. Piperine impairs cytochrome P4501A1 activity by direct interaction with the enzyme and not by down regulation of CYP1A1 gene expression in the rat hepatoma 5L cell line. Biochem. Biophys. Res. Commun. 1996; 218: 562–569
   PubMed Web of Science ®Google Scholar
• Reen R. K., Wiebel F. J., Singh J. Piperine inhibits aflatoxin B1-induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1. J. Ethnopharmacol. 1997; 58: 165–173
   PubMed Web of Science ®Google Scholar
• Reicks M. M., Crankshaw D. L. Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds. Nutr. Cancer 1996; 25: 241–248
   PubMed Web of Science ®Google Scholar
• Reiners J. J., Clift J. R., Mathieu P. Suppression of cell cycle progression by flavonoids: dependence on aryl hydrocarbon receptor. Carcinogenesis 1999; 20: 1561–1566
   PubMed Web of Science ®Google Scholar
• Rendic S., Di Carlo F. J. Human cytochrome P450 enzyme: a status report summarizing their reactions, substrates, induction, and inhibitors. Drug Metab. Rev. 1997; 29: 413–580
   PubMed Web of Science ®Google Scholar
• Renton K. W. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol. Ther. 2001; 92: 147–163
   PubMed Web of Science ®Google Scholar
• Rice-Evans C. Flavonoid antioxidants. Curr. Med. Chem. 2001; 8: 797–807
   PubMed Web of Science ®Google Scholar
• Rivory L. P., Slaviero K. A., Hoskins J. M., Clarke S. J. The erythromycin breath test for the prediction of drug clearance. Clin. Pharmacokinet. 2001; 40: 151–158
   PubMed Web of Science ®Google Scholar
• Roberts-Kirchhoff E. S., Crowley J. R., Hollenberg P. F., Kim H. Metabolism of genistein by rat and human cytochromes P450s. Chem. Res. Toxicol. 1999; 12: 610–616
   PubMed Web of Science ®Google Scholar
• Roby C. A., Anderson G. D., Kantor E., Dryer D. A., Burstein A. H. St. John's Wort: effect on CYP3A4 activity. Clin. Pharmacol. Ther. 2000; 67: 451–457
   PubMed Web of Science ®Google Scholar
• Rodrigues A. D. Use of in vitro human metabolism studies in drug development. Biochem. Pharmacol. 1994; 48: 2147–2156
   PubMed Web of Science ®Google Scholar
• Rodrigues A. D., Rushmore T. H. Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences. Curr. Drug Metab. 2002; 3: 289–309
   PubMed Web of Science ®Google Scholar
• Sahu S. C., Gray G. C. Kaempferol-induced nuclear DNA damage and lipid peroxidation. Cancer Lett. 1994; 85: 159–164
   PubMed Web of Science ®Google Scholar
• Sakai K., Saitoh Y., Ikawa C., Nishihata T. Effect of water extracts of aloe and some herbs in decreasing blood ethanol concentration in rats. II. Chem. Pharm. Bull. 1989; 37: 155–159
   PubMed Web of Science ®Google Scholar
• Schellens J. H. M., Malingre M. M., Kruijtzer C. M. F., Bardelmeijer H. A., van Tellingen O., Schinkel A. H., Beijnen J. H. Modulation of oral bioavailability of anticancer drugs: from mouse to man. Eur. J. Pharm. Sci. 2000; 12: 103–110
   PubMed Web of Science ®Google Scholar
• Schmider J., Brockmoller J., Arold G., Bauer S., Roots I. Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine. Pharmacogenetics 1999; 9: 725–734
   PubMedGoogle Scholar
• Schmiedlin-Ren P., Edwards D. J., Fitzsimmons M. E., He K., Lown K. S., Woster P. M., Rahman A., Thummel K. E., Fisher J. M., Hollenberg P. F., Watkins P. B. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab. Dispos. 1997; 25: 1228–1233
   PubMed Web of Science ®Google Scholar
• Sheen L. Y., Chen H. W., Kung Y. L., Liu C. T., Lii C. K. Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed high- and low-fat diets. Nutr. Cancer 1999a; 35: 160–166
   PubMed Web of Science ®Google Scholar
• Sheen L. Y., Sheu S. F., Tsai S. J., Meng R. H. C., Lii C. K. Effect of garlic active principle, diallyl disulfide, on cell viability, lipid peroxidation, glutathione concentration and its related enzyme activities in primary rat hepatocytes. Am. J. Chin. Med. 1999b; 27: 95–106
   PubMed Web of Science ®Google Scholar
• Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi—Journal of the Pharmaceutical Society of Japan 2000; 120: 849–862
   PubMed Web of Science ®Google Scholar
• Shih H., Pickwell G. V., Quattrochi L. C. Differential effects of flavonoid compounds on tumor-induced activation of the human CYP1A2 enhancer. Arch. Biochem. Biophys. 2000; 373: 287–294
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals. J. Pharmacol. Exp. Ther. 1994; 270: 414–423
   PubMed Web of Science ®Google Scholar
• Shinozuka K., Umegaki K., Kubota Y., Tanaka N., Mizuno H., Yamauchi J., Nakamura K., Kunitomo M. Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci. 2002; 70: 2783–2792
   PubMed Web of Science ®Google Scholar
• Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P. S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64: 353–356
   PubMed Web of Science ®Google Scholar
• Shukla Y., Taneja P. Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice. Cancer Lett. 2002; 176: 137–141
   PubMed Web of Science ®Google Scholar
• Siess M. H., Le Bon A. M., Canivenc-Lavier M. C., Suschetet M. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides. Cancer Lett. 1997; 120: 195–201
   PubMed Web of Science ®Google Scholar
• Sigusch H., Henschel L., Kraul H., Merkel U., Hoffmann A. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects. Pharmazie 1994; 49: 675–679
   PubMed Web of Science ®Google Scholar
• Silva I. D., Rodrigues A. S., Gaspar J., Laires A., Rueff J. Metabolism of galangin by rat cytochromes P450: relevance to the genotoxicity of galangin. Mutat. Res. 1997a; 393: 247–257
   PubMed Web of Science ®Google Scholar
• Silva I. D., Rodrigues A. S., Gaspar J., Maia R., Laires A., Rueff J. Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol. Mutagenesis 1997b; 12: 383–390
   PubMed Web of Science ®Google Scholar
• Singer A., Wonnemann M., Muller W. E. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+. J. Pharmacol. Exp. Ther. 1999; 290: 1363–1368
   PubMed Web of Science ®Google Scholar
• Singh J., Reen R. K. Modulation of constitutive, benz[a]anthracene- and phenobarbital-inducible cytochromes-P450 activities in rat hepatoma H4IIEC3/G- cells by piperine. Curr. Sci. 1994; 66: 365–369
   Web of Science ®Google Scholar
• Singh J., Reen R. K., Wiebel F. J. Piperine, a major ingredient of black and long peppers, protects against AFB1-induced cytotoxicity and micronuclei formation in H4IIEC3 rat hepatoma cells. Cancer Lett. 1994; 86: 195–200
   PubMed Web of Science ®Google Scholar
• Snyder R. Microsomal enzyme induction. Toxicol. Sci. 2000; 55: 233–234
   PubMed Web of Science ®Google Scholar
• Spigelski D., Jones P. J. Efficacy of garlic supplementation in lowering serum cholesterol levels. Nutr. Rev. 2001; 59: 236–241
   PubMed Web of Science ®Google Scholar
• Staffeldt B., Kerb R., Brockmoller J., Ploch M., Roots I. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract Li 160 in healthy volunteers. Nervenheilkunde 1993; 12: 331–338
   Web of Science ®Google Scholar
• Stohr J. R., Xiao P. G., Bauer R. Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro. J. Ethnopharmacol. 2001; 75: 133–139
   PubMed Web of Science ®Google Scholar
• Streetman D. S., Bertino J. S., Nafziger A. N. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 2000; 10: 187–216
   PubMedGoogle Scholar
• Stupans I., Stretch G., Hayball P. Olive oil phenols inhibit human hepatic microsomal activity. J. Nutr. 2000; 130: 2367–2370
   PubMed Web of Science ®Google Scholar
• Stupans I., Tan H. W., Kirlich A., Tuck K., Hayball P., Murray M. Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid. J. Pharm. Pharmacol. 2002; 54: 269–275
   PubMed Web of Science ®Google Scholar
• Sugimoto K., Ohmori M., Tsuruoka S., Nishiki K., Kawaguchi A., Harada K., Arakawa M., Sakamoto K., Masada M., Miyamori I., Fujimura A. Different effects of St. John's Wort on the pharmacokinetics of simvastatin and pravastatin. Clin. Pharmacol. Ther. 2001; 70: 518–524
   PubMed Web of Science ®Google Scholar
• Sun M. Z., Sakakibara H., Ashida H., Danno G., Kanazawa K. Cytochrome P4501A1-inhibitory action of antimutagenic anthraquinones in medicinal plants and the structure–activity relationship. Biosci. Biotechnol. Biochem. 2000; 64: 1373–1378
   PubMed Web of Science ®Google Scholar
• Tam L. S., Chan T. Y. K., Leung W. K., Critchley J. A. J. H. Warfarin Interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil. Aust. NZ J. Med. 1995; 25: 258
   PubMedGoogle Scholar
• Tang W., Stearns R. A. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug–drug interactions. Curr. Drug Metab. 2001; 2: 185–198
   PubMed Web of Science ®Google Scholar
• Tang Y. P., Lou F. C., Wang J. H., Li Y. F., Zhuang S. F. Coumaroyl flavonol glycosides from the leaves of Ginkgo biloba. Phytochemistry 2001; 58: 1251–1256
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W., Birkett D. J., Veronese M. E., McManus M. E., Tukey R. H., Quattrochi L. C., Gelboin H. V., Miners J. O. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther. 1993; 265: 401–407
   PubMed Web of Science ®Google Scholar
• Tateishi T., Asoh M., Nakura H., Watanabe M., Tanaka M., Kumai T., Kobayashi S. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chem-Biol. Interact. 1999; 117: 257–268
   PubMed Web of Science ®Google Scholar
• Teyssier C., Guenot L., Suschetet M., Siess M. H. Metabolism of diallyl disulfide by human liver microsomal cytochromes P-450 and flavin-containing monooxygenases. Drug Metab. Dispos. 1999; 27: 835–841
   PubMed Web of Science ®Google Scholar
• Tsukamoto S., Cha B. C., Ohta T. Dipiperamides A, B, and C: bisalkaloids from the white pepper Piper nigrum inhibiting CYP3A4 activity. Tetrahedron 2002; 58: 1667–1671
   Web of Science ®Google Scholar
• Tsyrlov I. B., Mikhailenko V. M., Gelboin H. V. Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochim. Biophys. Acta 1994; 1205: 325–335
   PubMed Web of Science ®Google Scholar
• Tucker G. T. The rational selection of drug interaction studies: implications of recent advances in drug metabolism. Intl J. Clin. Pharmacol. Ther. Toxicol. 1992; 30: 550–553
   PubMed Web of Science ®Google Scholar
• Tukey R. H., Strassburg C. P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Ann. Rev. Pharmacol. Toxicol. 2000; 40: 581–616
   PubMed Web of Science ®Google Scholar
• Ueng Y. F., Kuwabara T., Chun Y.-J., Guengerich F. P. Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 1997; 36: 370–381
   PubMed Web of Science ®Google Scholar
• Ueng Y. F., Jan W. C., Lin L. C., Chen T. L., Guengerich F. P., Chen C. F. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metab. Dispos. 2002; 30: 349–353
   PubMed Web of Science ®Google Scholar
• Ueng Y. F., Shyu C. C., Liu T. Y., Oda Y., Lin Y. L., Liao J. F., Chen C. F. Protective effects of baicalein and wogonin against benzo[a]pyrene- and aflatoxin B-1-induced genotoxicities. Biochem. Pharmacol. 2001a; 62: 1653–1660
   PubMed Web of Science ®Google Scholar
• Ueng Y. F., Wang J. J., Lin L. C., Park S. S., Chen C. F. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa. Life Sci. 2001b; 70: 207–217
   PubMed Web of Science ®Google Scholar
• Vaes L. P., Chyka P. A. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann. Pharmacother. 2000; 34: 1478–1482
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K., von Moltke L. L., Greenblatt D. J. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models. J. Clin. Pharmacol. 2001; 41: 1149–1179
   PubMed Web of Science ®Google Scholar
• Venkataramanan R., Ramachandran V., Komoroski B. J., Zhang S. M., Schiff P. L., Strom S. C. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab. Dispos. 2000; 28: 1270–1273
   PubMed Web of Science ®Google Scholar
• Vincent J., Harris S. I., Foulds G., Dogolo L. C., Willavize S., Friedman H. L. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. Br. J. Clin. Pharmacol. 2000; 50: 455–463
   PubMed Web of Science ®Google Scholar
• Waller C. L., McKinney J. D. Three-dimensional quantitative structure–activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem. Res. Toxicol. 1995; 8: 847–858
   PubMed Web of Science ®Google Scholar
• Wang H. W., Chen T. L., Yang P. C., Ueng T. H. Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. Drug Metab. Dispos. 2001; 29: 1229–1235
   PubMed Web of Science ®Google Scholar
• Wang M. Q., Guilbert L. J., Ling L., Li J., Wu Y. Q., Xu S., Pang P., Shan J. J. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J. Pharm. Pharmacol. 2001; 53: 1515–1523
   PubMed Web of Science ®Google Scholar
• Wang Z. Q., Gorski C., Hamman M. A., Huang S. M., Lesko L. J., Hall S. D. The effects of St. John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin. Pharmacol. Ther. 2001; 70: 317–326
   PubMed Web of Science ®Google Scholar
• Wang T., Shankar K., Ronis M. J. J., Mehendale H. M. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J. Pharmacol. Exp. Ther. 2000; 294: 473–479
   PubMed Web of Science ®Google Scholar
• Wang T., Shankar K., Bucci T. J., Warbritton A., Mehendale H. M. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality. Toxicol. Appl. Pharmacol. 2001; 173: 27–37
   PubMed Web of Science ®Google Scholar
• Wang B. H., Zuzel K. A., Rahman K., Billington D. Treatment with aged garlic extract protects against bromobenzene toxicity to precision cut rat liver slices. Toxicology 1999; 132: 215–225
   PubMed Web of Science ®Google Scholar
• Wargovich M. J., Woods C., Hollis D. M., Zander M. E. Herbals, cancer prevention and health. J. Nutr. 2001; 131: 3034S–3036S
   PubMed Web of Science ®Google Scholar
• Wentworth J. M., Agostini M., Love J., Schwabe J. W., Chatterjee V. K. St. John's wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol. 2000; 166: R11–R16
   PubMed Web of Science ®Google Scholar
• Wieling J., Tamminga W. J., Sakiman E. P., Oosterhuis B., Wemer J., Jonkman J. H. G. Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening. Ther. Drug Monitor. 2000; 22: 486–496
   PubMed Web of Science ®Google Scholar
• Wills R. B. H., Bone K., Morgan M. Herbal products: active constituents, modes of action and quality control. Nutr. Res. Rev. 2000; 13: 47–77
   PubMed Web of Science ®Google Scholar
• Wonnemann M., Singer A., Siebert B., Muller W. E. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort. Pharmacopsychiatry 2001; 34: S148–S151
   PubMed Web of Science ®Google Scholar
• Wormhoudt L. W., Commandeur J. N. M., Vermeulen N. P. E. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit. Rev. Toxicol. 1999; 29: 59–124
   PubMed Web of Science ®Google Scholar
• Wu W. L., Chang W. L., Chen C. F. Cytotoxic activities of tanshinones against human carcinoma cell lines. Am. J. Chin. Med. 1991; 19: 207–216
   PubMed Web of Science ®Google Scholar
• Wu C. C., Sheen L. Y., Chen H. W., Kuo W. W., Tsai S. J., Lii C. K. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats. J. Agric. Food Chem. 2002; 50: 378–383
   PubMed Web of Science ®Google Scholar
• Xie W., Evans R. M. Orphan nuclear receptors: the exotics of xenobiotics. J. Biol. Chem. 2001; 276: 37739–37742
   PubMed Web of Science ®Google Scholar
• Yang C. S., Chhabra S. K., Hong J. Y., Smith T. J. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J. Nutr. 2001; 131: 1041S–1045S
   PubMed Web of Science ®Google Scholar
• Yao D. G., Ding S. H., Burchell B., Wolf C. R., Friedberg T. Detoxication of vinca alkaloids by human P450CYP3A4-mediated metabolism: implications for the development of drug resistance. J. Pharmacol. Exp. Ther. 2000; 294: 387–395
   PubMed Web of Science ®Google Scholar
• Yee G. C., Stanley D. L., Pessa J. L., Costa T. D., Beltz S. E., Ruiz J., Lowenthal D. T. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995; 345: 955–956
   PubMed Web of Science ®Google Scholar
• Yin J., Wennberg R. P., Miller M. Induction of hepatic bilirubin and drug metabolizing enzymes by individual herbs present in the traditional Chinese medicine, yin zhi huang. Dev. Pharmacol. Ther. 1993; 20: 186–194
   PubMedGoogle Scholar
• Yokozawa T., Chen C. P., Dong E., Tanaka T., Nonaka G. I., Nishioka I. Study on the inhibitory effect of tannins and flavonoids against the 1,1-diphenyl-2-picrylhydrazyl radical. Biochem. Pharmacol. 1998; 56: 213–222
   PubMed Web of Science ®Google Scholar
• Yu C. M., Chan J. C., Sanderson J. E. Chinese herbs and warfarin potentiation by ‘danshen’. J. Int. Med. 1997; 241: 337–339
   PubMed Web of Science ®Google Scholar
• Yue Q. Y., Bergquist C., Gerden B. Safety of St John's wort (Hypericum perforatum). Lancet 2000; 355: 548–549
   PubMed Web of Science ®Google Scholar
• Zdunczyk Z., Frejnagel S., Wroblewska M., Juskiewicz J., Oszmianski J., Estrella I. Biological activity of polyphenol extracts from different plant sources. Food Res. Intl 2002; 35: 183–186
   Web of Science ®Google Scholar
• Zhai S., Dai R., Friedman F. K., Vestal R. E. Comparative inhibition of human cytochromes P4501A1 and 1A2 by flavonoids. Drug Metab. Dispos. 1998; 26: 989–992
   PubMed Web of Science ®Google Scholar
• Zhang Y. C., Benet L. Z. The gut as a barrier to drug absorption—combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet. 2001; 40: 159–168
   PubMed Web of Science ®Google Scholar
• Zhao C., Shichi H. Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine. J. Ocul. Pharmacol. Ther. 1998; 14: 345–355
   PubMed Web of Science ®Google Scholar
• Zheng S., Yang H., Zhang S., Wang X., Yu L. L., Lu J. Q., Li J. Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J. Cell. Biochem. 1997; Suppl. 27: 106–112
   Google Scholar
• Zhu M., Chan K. W., Ng L. S., Chang Q., Chang S., Li R. C. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Pharm. Pharmacol. 1999; 51: 175–180
   PubMed Web of Science ®Google Scholar
• Zhu B., Ou-Yang D. S., Chen X. P., Huang S. L., Tan Z. R., He N., Zhou H. H. Assessment of cytochrome P450 activity by a five-drug cocktail approach. Clin. Pharmacol. Ther. 2001; 70: 455–461
   PubMed Web of Science ®Google Scholar